1. Home
  2. News & Press
  3. GeneSight Mental Health Monitor: Special Election Series Update

GeneSight Mental Health Monitor: Special Election Series Update

News & Press
Americans’ anxiety toward upcoming Presidential election has increased; mental health expert encourages treatment for those who are impacted

Phase II of GeneSight® Mental Health Monitor Election Survey from Myriad Genetics Shows 41% of Americans Report Feeling Anxious as the Election Draws Closer

A growing number of Americans are reporting that their moods, anxiety and/or depression continue to be negatively impacted by the upcoming Presidential election according to the latest GeneSight® Mental Health Monitor: Special Election Series, a nationwide survey from Myriad Genetics, Inc., a leader in genetic testing and precision medicine.

“In my role, I am not surprised that people are feeling more anxious given the unprecedented events that have already occurred leading up to this election,” said Thomas J. Valente MD, a psychiatrist from Leesburg, Florida. “With three months still to go, I encourage anyone feeling high levels of anxiousness about the election, politics, or the state of the world to consider seeking treatment.”

As election campaigning is ramping up, there is evidence that more Americans are feeling the impacts. According to the survey results:

  • Just 43% report their moods are not impacted by the election as of July, whereas in May, 54% reported their moods weren’t impacted.
  • 75% of those already suffering from anxiety and/or depression report that their moods are being negatively affected by the election, an increase from 66% in May.
  • 47% of Americans now feel the news and social media around the upcoming Presidential election has made them more anxious than usual, an increase from 38% in May.


The latest monitor results are the second of three in a series tracking how the election season may affect Americans’ mental health, particularly amidst the ongoing mental health crisis in the United States. The third survey of the GeneSight Special Election Series will follow in October.

Dr. Valente encourages those who are struggling with anxiety and/or depression to consider the GeneSight test as part of their treatment plan. “In my practice, the GeneSight test has helped me quickly identify a more appropriate medication, which helps my patients feel better faster.”

The GeneSight Psychotropic test is a genetic test that shows healthcare providers how their patient’s genes may affect how they break down or respond to certain medications commonly prescribed to treat depression, anxiety and other mental health conditions. The GeneSight test reveals which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects based on the patient’s DNA.

Read more:

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

About the GeneSight Mental Health Monitor

The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. Phase I was conducted between May 8-15, 2024, and Phase II was conducted between July 23-30, 2024, among a representative sample (n=1000) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, region, ethnicity).

In addition to the nationally representative sample, a statistically reliable sample was desired of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. The study also used mental health screening instruments, the Patient Health Questionnaire-2 (PHQ-2) for depression, and the General Anxiety Disorder (GAD-2) for anxiety, to better understand this population.

ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.

Healthcare Provider

PRIME Meta Analysis

In 2022, the United States Department of Veterans Affairs (VA) undertook the Precision Medicine in Mental Health Care, or PRIME Care study, the largest phar...

Read more

    Learn more

    Learn more about GeneSight
    How to talk to your provider
    View our clinical studies

    Take the next step with the GeneSight test

    Take a step closer to getting the GeneSight test or registering to provide the test to your patients. We will follow up with additional information either via email or phone.

    The GeneSight test must be ordered by a registered clinician. If you are a patient, caregiver or office staff who would like a clinician to be registered to administer the GeneSight test, please include their name and contact information.

    If you are a current registered provider or tested patient, please contact us.

    Take the Next Step - PD

    1. Step 1
    2. Step 2
    3. Step 3
    Please provide us with your name



    1. Step 1
    2. Step 2
    3. Step 3
    Please provide contact and clinic information
    Please provide contact information

    We are asking for Date of Birth for data verification purposes.










    We are asking for Date of Birth for data verification purposes.

    If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.







    Your clinician who is currently managing your medication and making treatment decisions can order your GeneSight test.

    If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.

    Please provide your clinician's information
    The GeneSight test must be ordered by your clinician








    1. Step 1
    2. Step 2
    3. Step 3

    How can we help?
    When completed, we'll follow up with more information
    Please let us know how we can best help you
    When completed, we'll follow up with more information


    Already taken the GeneSight test and need access to your results?








    Contact Information

    By submitting this form, you authorize Myriad to contact you about your inquiry via email and/or phone (including SMS/text message). Additionally, please note communications may be unsecure and carry typical risks associated with such transmissions. By submitting this form, you also acknowledge that you understand the foregoing warning and understand the typical risk of email and phone transmissions. For further information on our privacy practices, including information about opting-out of communications for Myriad, please visit our Privacy Notice and Notice of Privacy Practices.

    Chat